Stay updated on Semaglutide Aids Weight Loss in Type 2 Diabetes: Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Aids Weight Loss in Type 2 Diabetes: Clinical Trial page.

Latest updates to the Semaglutide Aids Weight Loss in Type 2 Diabetes: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry Revision: v3.3.3 was added. The items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe history now includes a new revision entry (v3.3.2) and removes the older entry (v3.2.0), affecting only the version log of the page.SummaryDifference0.1%

- Check48 days agoChange DetectedThe top funding-status notice/administrative banner was removed, which does not affect the trial data or visible study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedThe new screenshot includes updates to the study status and recruitment status, as well as changes to the contacts/locations section. These updates reflect current trial activity and site information.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Contacts/Locations, Study Design, and Study Status in the latest version (33) on 2025-10-23, with a deletion recorded on 2024-12-20.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference11%

Stay in the know with updates to Semaglutide Aids Weight Loss in Type 2 Diabetes: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Aids Weight Loss in Type 2 Diabetes: Clinical Trial page.